Panakeia offers an AI platform to enable simplified, rapid diagnostics to inform the precision treatment of cancer.

Founded in 2018 and based in London, England, Panakeia is a privately held company in the software development industry. Their specialties include machine learning, deep learning, artificial intelligence, cancer diagnostics, and personalized medicine.

Panakeia aims to make precision cancer care faster, more accessible, and scalable through AI-powered molecular profiling. Their technology transforms tissue images into molecular insights faster than other methods, revolutionizing how clinicians detect and treat cancer. The company is dedicated to ethical and safe AI to improve patient care worldwide.